U.S. Retail Distributors Stock News

Why EMBERPOINT matters for Lockheed Martin stock Lockheed Martin (LMT) has joined forces with PG&E Corporation, Salesforce and Wells Fargo to launch EMBERPOINT LLC, a new venture focused on AI powered wildfire detection, prevention and response solutions. This move takes Lockheed Martin into civilian wildfire mitigation by using its layered prediction, detection and autonomous response systems. The partners contribute utility experience, real time data platforms and funding support for the...

Navitas Semiconductor (NVTS) is in the middle of a major reset, moving away from mobile and consumer components tied to China toward AI focused power chips for data centers, and that shift is already pressuring near term revenue. See our latest analysis for Navitas Semiconductor. The share price has been volatile as this reset unfolds, with a 29.19% 1 month share price return and a 14.08% year to date share price return, alongside a very large 1 year total shareholder return of 220.81%. This...

In recent weeks, Meta Platforms paid Oklo US$25,000,000 upfront for phase one of an advanced nuclear energy campus in Ohio, while Oklo also highlighted upcoming isotope revenue and drew a Buy rating upgrade from Bank of America. These developments, reinforced by public support for nuclear energy at Davos and active options trading, underscore Oklo’s growing role at the intersection of clean power, data centers, and advanced nuclear technology. Next, we’ll examine how the Meta reactor...

H&R Block (NYSE:HRB) has added three new members to its Board of Directors: Geralyn R. Breig, Christian H. Charnaux, and Stephanie C. Plaines. The appointments bring experience from consumer brands, hospitality, and retail finance to the company. The board refresh points to a potential shift in how H&R Block thinks about its business mix, customer reach, and capital decisions. H&R Block shares recently closed at $39.29, with the stock showing a 150.2% return over 5 years and 10.2% over 3...

Herbalife has recently faced pressure from declining unit sales, softer product demand, and share issuance that has reduced earnings per share despite prior earnings beats. At the same time, Herbalife is promoting its wellness-focused brand through initiatives like Herbalife India’s “Live Your Best Life, Unscripted” podcast, underscoring a push to deepen consumer engagement amid these business headwinds. We’ll now examine how Herbalife’s weakening sales volumes and earnings dilution shape...

Merck (NYSE:MRK) has ended acquisition talks with Revolution Medicines after disagreements over valuation. The discussions focused on a potential multibillion dollar oncology deal that had drawn significant industry attention. The decision highlights current hurdles for large pharma companies seeking biotech deals, especially for cancer assets. For you as an investor, this development sits at the intersection of Merck's core oncology focus and broader pharma deal activity. Merck is known...

Hershey (HSY) is back in focus as investors weigh falling cocoa costs, sustained higher shelf prices, and an upcoming earnings report. Estimates have been revised upward, even while some analyst ratings remain neutral. See our latest analysis for Hershey. At a share price of $191.63, Hershey has a 90 day share price return of 9.33% and a 1 year total shareholder return of 32.18%. The 3 year total shareholder return of a 7.49% decline contrasts with the 5 year total shareholder return of...

If you are wondering whether Palo Alto Networks is priced attractively or already baking in big expectations, its recent share performance offers a useful starting point. The stock last closed at US$183.50, with returns of a 0.3% decline over 7 days, a 2.6% decline over 30 days, a 2.3% gain year to date, and a 4.9% decline over the past year, while the 3 year and 5 year returns sit at 131.3% and 184.2% respectively. Recent headlines around Palo Alto Networks have focused on its role as a...

Why sentiment around LegalZoom.com (LZ) has turned cautious Recent analysis points to weaker near and mid-term sentiment for LegalZoom.com (LZ), with the loss of key long-term support signals and a higher perceived risk of further downside influencing recent trading activity. See our latest analysis for LegalZoom.com. At a share price of US$8.88, LegalZoom.com has seen a 30 day share price return of 11.90% and a year to date share price return of 7.40%. The 1 year total shareholder return of...

Why Simon Property Group Is Back on Investor Radars Simon Property Group (SPG) has been drawing fresh attention as investors revisit large retail REITs, with the stock recently closing at $184.56 and showing mixed returns over the past month and past 3 months. See our latest analysis for Simon Property Group. Recent trading has been choppy rather than one way, with a modest 90-day share price return of 6.29% sitting alongside a 10.42% 1-year total shareholder return. This suggests interest in...

Recent performance snapshot and why Sinclair is on investors’ radar Without a specific headline event, Sinclair (SBGI) is catching attention mainly because of its mixed recent performance, with the share price around $14.80 and returns that have moved differently over shorter and longer periods. Over the past day and past week, the stock has shown declines of about 2.9% and 2.7%, and over the past month it is down roughly 3%. By contrast, the past 3 months show a gain of about 12.4%, and the...

Lemonade (NYSE:LMND) has introduced a data driven autonomous car insurance product for Tesla Full Self Driving vehicles. The product uses real world autonomous driving data and technical collaboration with Tesla to set per mile rates that are significantly lower for FSD enabled driving. The launch positions Lemonade as an early mover in insurance products designed specifically around autonomous vehicle behavior and real time data. Lemonade is rolling out this Tesla focused product at a time...

Sunrun recently announced a partnership with HA Sustainable Infrastructure Capital to finance 300 megawatts of new home-based power plants, with HA committing US$500 million over 18 months while Sunrun retains ownership of the assets. This deal highlights how Sunrun is grouping thousands of residential systems into virtual power plants that can supply utilities with grid-supporting capacity as electricity demand evolves. Next, we’ll examine how this US$500 million virtual power plant...

If you are wondering whether Pediatrix Medical Group is attractively priced after its recent run, this article will walk through what the current share price might be implying about its value. The stock last closed at US$20.53, with returns of 42.0% over 1 year and 33.7% over 3 years. However, the last 7 days, 30 days and year to date show declines of 5.5%, 6.1% and 3.6% respectively. Recent share price moves have put more attention on how the business is being valued. This is why many...

CleanSpark (NasdaqCM:CLSK) has acquired land in Texas to build a large-scale data center for artificial intelligence and high-performance computing. The planned facility is intended to use the company’s existing power and land expertise to support AI and HPC workloads alongside its bitcoin mining operations. This move reflects a broader push by CleanSpark to position itself in data infrastructure markets. CleanSpark, trading at $13.27, has had a mixed return profile, with its 3 year...

TD Cowen recently downgraded Stryker’s rating from “Buy” to “Hold,” arguing that the current share valuation already factors in potential earnings growth. The move highlights how even a company with a strong position in medical devices can prompt caution when expectations appear fully reflected in its share price. We’ll now examine how TD Cowen’s valuation concerns shape Stryker’s investment narrative and what this reassessment could mean for investors. This technology could replace...

Becton, Dickinson and Company recently declared a quarterly dividend of US$1.05 per share, authorized a US$250 million share repurchase program with no expiration, and advanced its portfolio with AI-enabled research tools and a newly cleared breast biopsy system. Together, these shareholder return plans and higher-value product launches underscore how BD is coupling capital returns with investments in diagnostics and life sciences innovation. Next, we’ll examine how BD’s new US$250 million...

Peloton Interactive (NasdaqGS:PTON) and Respin Health report results from a targeted study on women experiencing perimenopause and menopause. The program combined curated fitness content with education focused on symptom management. Participants in the study saw meaningful improvement in menopause related symptoms based on the intervention. For Peloton, best known for its connected bikes, treadmills, and subscription content, this kind of targeted health program points to a broader role in...

NGL Energy Partners (NGL) has drawn fresh attention after surpassing revenue forecasts while reporting earnings per share below expectations. This mix coincided with a positive share price reaction and renewed interest in its midstream operations. See our latest analysis for NGL Energy Partners. That strong revenue print and the recent 52 week high have come alongside a 90 day share price return of 78.28% and a 1 year total shareholder return of 108.59%, so recent momentum is building on...

Caterpillar announced that longtime executive Tony Fassino will retire in May 2026, with Rod Shurman stepping up as group president of Construction Industries from February 1, 2026, to oversee key global divisions and a major manufacturing and supply base. This leadership transition arrives as Caterpillar’s construction and power solutions businesses are in focus for their role in AI data centers and large-scale infrastructure projects, making management continuity particularly important for...

Jabil (NYSE:JBL) reported significant board changes following its annual meeting, with two directors offering to resign after not receiving majority shareholder support. The company appointed three new directors to its board, including a new Chairman, marking a major refresh of its leadership at the board level. These moves introduce fresh oversight and could influence how Jabil sets priorities for capital allocation, risk management, and long term planning. Jabil is a manufacturing...

FDA approved a new DARZALEX FASPRO combination regimen for newly diagnosed multiple myeloma patients who are not eligible for stem cell transplant, marking the drug’s twelfth indication. New Phase 3 data for TECVAYLI in relapsed or refractory multiple myeloma showed significant progression free and overall survival benefits in hard to treat patients. The updates expand Johnson & Johnson’s oncology portfolio within its pharmaceutical and MedTech businesses. For investors watching Johnson &...

Medical Properties Trust has recently drawn attention as call option trading volume surged to several times typical levels, pushing up implied volatility ahead of its February 26 earnings release. This combination of heavier-than-usual options activity and improving earnings estimates signals that many market participants are positioning for meaningful news around the upcoming results. With this backdrop of elevated call option activity, we will examine how these expectations shape Medical...

In its fourth-quarter 2025 investor letter, Meridian Growth Fund reported that Certara, Inc. underperformed after service bookings came in weaker than expected, prompting management to slightly lower guidance. The fund also pointed to Certara’s ongoing transformation under a new CEO, including a more commercially focused approach and potential sale of a non-core business, even as its biosimulation tools supported a majority of recent FDA drug approvals. Next, we’ll examine how softer...